noun A liquid biopsy is a medical test that involves analyzing a sample of blood or other bodily fluids to detect cancer cells or genetic material.
Liquid biopsy is used in oncology for early cancer detection, monitoring treatment response, and detecting resistance mutations.
Liquid biopsy is utilized in clinical research for non-invasive monitoring of disease progression and treatment efficacy.
In genomics, liquid biopsy is used to analyze circulating tumor DNA (ctDNA) for genetic mutations.
Liquid biopsy plays a key role in precision medicine by providing real-time information on tumor genetics and guiding personalized treatment strategies.
This field focuses on the development and optimization of liquid biopsy techniques such as analyzing circulating tumor cells (CTCs) and exosomes.
Researchers study specific biomarkers present in liquid biopsies to identify cancer types and predict patient outcomes.
Liquid biopsy is used in medical writing to discuss the latest advancements in cancer detection and monitoring using blood samples.
Psychologists may use information about liquid biopsy in research or counseling sessions when discussing the emotional impact of cancer diagnosis and treatment.
Oncologists frequently use liquid biopsy results to guide treatment decisions, monitor disease progression, and assess response to therapy in cancer patients.
Genetic counselors may incorporate information about liquid biopsy in genetic testing discussions with individuals at risk for hereditary cancers.
Biomedical researchers utilize liquid biopsy technology to study circulating tumor DNA and explore new ways to improve cancer diagnosis and treatment.